| Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy JS Thurlow, M Joshi, G Yan, KC Norris, LY Agodoa, CM Yuan, R Nee American journal of nephrology 52 (2), 98-107, 2021 | 413 | 2021 |
| Thrombotic microangiopathy after renal transplantation in the United States JC Reynolds, LY Agodoa, CM Yuan, KC Abbott American journal of kidney diseases 42 (5), 1058-1068, 2003 | 241 | 2003 |
| Long-term ouabain administration produces hypertension in rats. CM Yuan, P Manunta, JM Hamlyn, S Chen, E Bohen, J Yeun, FJ Haddy, ... Hypertension 22 (2), 178-187, 1993 | 196 | 1993 |
| Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation RT Neff, FP Hurst, EM Falta, EM Bohen, KL Lentine, VR Dharnidharka, ... Transplantation 86 (10), 1474-1478, 2008 | 155 | 2008 |
| Renal biopsy in high-risk patients with medical diseases of the kidney KP Stiles, CM Yuan, EM Chung, RD Lyon, JD Lane, KC Abbott American journal of kidney diseases 36 (2), 419-433, 2000 | 143 | 2000 |
| Parathyroidectomy versus cinacalcet hydrochloride–based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis R Narayan, RM Perkins, EP Berbano, CM Yuan, RT Neff, ES Sawyers, ... American Journal of Kidney Diseases 49 (6), 801-813, 2007 | 141 | 2007 |
| Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease SW Olson, CB Arbogast, TP Baker, D Owshalimpur, DK Oliver, KC Abbott, ... Journal of the American Society of Nephrology 22 (10), 1946-1952, 2011 | 127 | 2011 |
| Damned if you do, damned if you don't: potassium binding resins in hyperkalemia M Watson, KC Abbott, CM Yuan Clinical journal of the American Society of Nephrology 5 (10), 1723-1726, 2010 | 123 | 2010 |
| Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies KL Lentine, FP Hurst, RM Jindal, TC Villines, JS Kunz, CM Yuan, ... American journal of kidney diseases 55 (1), 152-167, 2010 | 105 | 2010 |
| Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial RM Perkins, MC Aboudara, AL Uy, SW Olson, HM Cushner, CM Yuan American journal of kidney diseases 53 (4), 606-616, 2009 | 95 | 2009 |
| Factors associated with improved short term survival in obese end stage renal disease patients CW Glanton, IO Hypolite, PB Hshieh, LY Agodoa, CM Yuan, KC Abbott Annals of epidemiology 13 (2), 136-143, 2003 | 94 | 2003 |
| Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study MA Watson, TP Baker, A Nguyen, ME Sebastianelli, HL Stewart, DK Oliver, ... American Journal of Kidney Diseases 60 (3), 409-416, 2012 | 93 | 2012 |
| Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression KC Abbott, CM Yuan, AJ Taylor, DF Cruess, LYC Agodoa Journal of the American Society of Nephrology 14 (9), 2358-2365, 2003 | 84 | 2003 |
| Effects of three sodium-potassium adenosine triphosphatase inhibitors. MB Pamnani, S Chen, HJ Bryant, JF Schooley Jr, DC Eliades, CM Yuan, ... Hypertension 18 (3), 316-324, 1991 | 80 | 1991 |
| Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center CM Yuan, R Nee, KA Ceckowski, KR Knight, KC Abbott Clinical kidney journal 10 (2), 257-262, 2017 | 77 | 2017 |
| Life expectancy benefits of cancer screening in the end-stage renal disease population CJ LeBrun, LF Diehl, KC Abbott, PG Welch, CM Yuan American journal of kidney diseases 35 (2), 237-243, 2000 | 59 | 2000 |
| Survival disparity of African american versus Non–African american patients with ESRD Due to SLE R Nee, J Martinez-Osorio, CM Yuan, DJ Little, MA Watson, L Agodoa, ... American Journal of Kidney Diseases 66 (4), 630-637, 2015 | 58 | 2015 |
| Transjugular renal biopsy in high-risk patients: an American case series KC Abbott, FM Musio, EM Chung, NN Lomis, JD Lane, CM Yuan BMC nephrology 3, 1-6, 2002 | 55 | 2002 |
| The impact of bleeding times on major complication rates after percutaneous real-time ultrasound-guided renal biopsies. KP Stiles, C Hill, CJ LeBrun, B Reinmuth, CM Yuan, KC Abbott Journal of Nephrology 14 (4), 275-279, 2001 | 55 | 2001 |
| Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats. MB Pamnani, S Chen, CM Yuan, FJ Haddy Hypertension 23 (1_supplement), I106, 1994 | 54 | 1994 |
Kevin AbbottProfessor of Medicine, USUHS, Program Officer, NIDDK, NIHVerified email at nih.gov
